Discover open access scientific publications

Search, annotate, share and cite publications

Publications by George Tsirakis

Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma

Journal of Hematology and Oncology

English

Miliary Tuberculosis With No Pulmonary Involvement in Myelodysplastic Syndromes: A Curable, Yet Rarely Diagnosed, Disease: Case Report and Review of the Literature

Annals of Clinical Microbiology and Antimicrobials

English

Related publications

Bone Destruction in Multiple Myeloma

Annals of the New York Academy of Sciences

Philosophy of Science

2006

English

Bone Marrow Angiogenesis in Multiple Myeloma

English

NEK2 Induces Osteoclast Differentiation and Bone Destruction via Heparanase in Multiple Myeloma

English

Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma

English

Angiogenesis and Its Therapeutic Implication 5. Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma

Internal Medicine

Medicine

2003

English

Dual Causes of Multiple Myeloma

International Journal of Case Reports and Images

2013

English

Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma

British Journal of Cancer

Cancer Research

Oncology

2001

English

Evaluating Biomarkers of Neuronal Degeneration and Neuroinflammation in CSF of Patients With Multiple Sclerosis–osteopontin as a Potential Marker of Clinical Severity

Journal of the Neurological Sciences

Neurology

2013

English

Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?

Cytometry Part B - Clinical Cytometry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by George Tsirakis

Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma

Miliary Tuberculosis With No Pulmonary Involvement in Myelodysplastic Syndromes: A Curable, Yet Rarely Diagnosed, Disease: Case Report and Review of the Literature

Related publications

Bone Destruction in Multiple Myeloma

Bone Marrow Angiogenesis in Multiple Myeloma

NEK2 Induces Osteoclast Differentiation and Bone Destruction via Heparanase in Multiple Myeloma

Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma

Angiogenesis and Its Therapeutic Implication 5. Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma

Dual Causes of Multiple Myeloma

Serum Bone Sialoprotein as a Marker of Tumour Burden and Neoplastic Bone Involvement and as a Prognostic Factor in Multiple Myeloma

Evaluating Biomarkers of Neuronal Degeneration and Neuroinflammation in CSF of Patients With Multiple Sclerosis–osteopontin as a Potential Marker of Clinical Severity

Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?